With funding from the A-T Children’s Project and the Australian-based BrAshA-T organization, a team of researchers in Australia is using neuroimaging technology to learn more about abnormal circuitry and inflammation in the brains of A-T patients, possibly providing clues for therapeutic targets and uncovering imaging biomarkers for use in clinical trials.

Stephen Rose, PhD, Kate Sinclair, MD and Martin Lavin, PhD from the University of Queensland and Royal Children’s Hospital in Brisbane, Australia will work together on a grant entitled, “Investigating connectivity and neuroinflammation within corticomotor networks in A-T: Improving our understanding of the clinical phenotype.” Their study will recruit up to 20 patients with A-T and 20 age-matched, healthy controls from the Australian A-T Clinic as well as the New Zealand and Oceanic regions.

Dr. Rose and his team are using diffusion MRI (dMRI) for the analysis of brain circuitry and PET scans to detect the presence of brain inflammation. Combined, the two technologies may provide important imaging markers for evaluating both disease progression in A-T and new drug interventions that may slow or stop this progression.

Contact Us

Related News

Mar 2 @ 2:29 pm

Looking Forward to Research Advances in 2024

Dear Friends, As 2023 is wrapping up, we want to thank all of you who support the A-T…

more
Mar 2 @ 2:29 pm

A-T Biomarker Development Initiative Now Recruiting

On December 18, the A-T Children’s Project sent out the below email to A-T parents in the United…

more
Mar 2 @ 2:29 pm

A-T Caregiver Weekend 2024 Announced

On December 15, the A-T Children’s Project sent the below email to parents inviting them to join us…

more
Mar 2 @ 2:29 pm

Giving Tuesday Update 2023

It’s Giving Tuesday, and anonymous donors have joined together to match the first $60,000 in donations we receive!

more